To Fight the Opioid Epidemic and Protect Women’s Health, We Need All Tools in the Toolkit, and that Includes a Strong Title X Program This Woman’s History Month, we want to highlight a public health program that throughout its history has played a key role in giving women a critically important entry point into the […]
Best Practices for Reaching, Educating and Engaging Diverse Communities in Clinical Trials through Strategic Partnerships There is a lot of buzz around patient engagement and what it means to have patients as partners. These conversations usually involve patients, the organizations that serve and represent them, and industry. Topics are focused on ways to ensure that […]
Bobby Clark is a principal of HCM Strategists’ Health Innovation Team, and a recognized leader on U.S. health policy. He currently advises organizations on how to navigate shifting trends in the U.S. health marketplace, as well as the policy and political landscape. Bobby is also working to pilot a new public sector management practice at […]
I am typically not a fan of self-congratulation, but when reflecting on 2018, I end the year feeling more hopeful than I started it. HCM Strategists, an organization I founded with Kristin Hultquist and Michael Manganiello, turned 10 this year and has grown from three people hanging out in my living room to a company with […]
Lessons from the midterms and a Federal and State Outlook for Postsecondary Education: While Congress races to finish business during the lame duck session, there is quiet and sure momentum at both levels of government and across parties to help more adults get the postsecondary skills they need to survive in today’s economy. Earlier this month, […]
Is your state working to help more people earn college credentials? Perhaps someone you know dreams of going back to college to finally earn that degree. A sampling of recent headlines from across the country suggests we might be reaching critical mass on the issue.
When I reached out to a leading clinician in the field for some guidance and advice – which he provided – he put it diplomatically, “treating IBD is as much about art as it is about science.” I knew this already, but it didn’t make it any easier to hear it from a leading expert. I learned early after her diagnosis that there was no handbook.
A patient with diabetes can expect many things, including the unexpected. But perhaps patients should begin to start expecting more from their providers, from the drug industry, from insurance companies, from the government, and from their own community.
Today is your day. World Diabetes Day. Today the world will talk about you. They should be talking: nearly 86 million Americans have pre diabetes, and over 75 million of them don’t know it. Nearly 30 million American’s have diabetes, and of those 8 million aren’t aware. It is clear, Diabetes, you don’t discriminate which bodies you show up in. So across all continents, all borders and all populations, people are talking.
Great ideas can go awry simply because preferences and input were not considered. It is true when planning a party and it is also true when designing a clinical trial or when reviewing drugs and devices. The patient community recognized that this critical ingredient was missing in the regulatory review process at FDA and worked with Congress to address it.